Bactericidal activity of DU-6859a compared to activities of three quinolones, three beta-lactams, clindamycin, and metronidazole against anaerobes as determined by time-kill methodology
- 1 April 1997
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 41 (4) , 847-849
- https://doi.org/10.1128/aac.41.4.847
Abstract
The activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, piperacillin, piperacillin-tazobactam, imipenem, clindamycin, and metronidazole against 11 anaerobes were tested by the broth microdilution and time-kill methods. DU-6859a was the most active drug tested (broth microdilution MICs, 0.06 to 0.5 microg/ml), followed by imipenem (MICs, 0.002 to 4.0 microg/ml). Broth macrodilution MICs were within 3 (but usually 1) dilutions of the broth microdilution MICs. All compounds were bactericidal at the MIC after 48 h; after 24 h, 90% killing was shown for all strains when the compounds were used at four times the MIC. DU-6859a at < or = 0.5 microg/ml was bactericidal after 48 h.Keywords
This publication has 11 references indexed in Scilit:
- In vitro antibacterial activity of DU-6859a, a new fluoroquinoloneAntimicrobial Agents and Chemotherapy, 1995
- Quinolone Activity against AnaerobesDrugs, 1995
- In vitro activity of DU-6859a against anaerobic bacteriaAntimicrobial Agents and Chemotherapy, 1994
- Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methodsAntimicrobial Agents and Chemotherapy, 1994
- Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycinAntimicrobial Agents and Chemotherapy, 1994
- In vitro activity of DU-6859a, a new fluorocyclopropyl quinoloneAntimicrobial Agents and Chemotherapy, 1993
- The in-vitro activity of a new highly active quinolone, DU-6859aJournal of Antimicrobial Chemotherapy, 1993
- In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolatesJournal of Antimicrobial Chemotherapy, 1993
- Beta-lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolatesAntimicrobial Agents and Chemotherapy, 1992